Samarium Trifluoroacetylacetonate Market Key Highlights:
- Market Size (2024): USD 51.89 Million
- Projected Market Size (2034): USD 113.06 Million
- CAGR (2023-2034): 8.1%
Pricing Analysis:
- Price Growth
- Regional Variations
Volume Analysis:
Import-Export Data
- Major Importers
- Major Exporters
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
Price by Manufacturer
- Examination of pricing strategies adopted by various manufacturers.
Samarium Trifluoroacetylacetonate Market
The samarium trifluoroacetylacetonate market is growing as trifluoroacetylacetonate is one of the many organometallic compounds. Organometallics are useful reagents, catalysts, and precursors and have applications in thin films deposition, industrial chemistry, pharmaceuticals, LED manufacturing. It is also used in the production of luminescent materials and as an additive in fiber optic and laser manufacturing.
According to the journal Inorganic Chemistry Communications, Exploration of the newly developed red luminescent products of samarium for display applications. Optical band gap values lie in semiconductor materials and are responsible for the use of these compounds in luminescent display devices.
The demand for the samarium trifluoroacetylacetonate market continues growth with the application of samarium trifluoroacetylacetonate in the treatment of cancer radiopharmaceuticals and ongoing studies, particularly in bone metastasis. It is used as a precursor in the synthesis of other samarium compounds and as a catalyst in various organic chemical reactions. The compound has also been studied for its potential use as a contrast agent in biological imaging and magnetic resonance imaging (MRI). For instance, in September 2024, Sanofi signed an exclusive license agreement with RadioMedix, Inc. US clinical-stage biotechnology company developing radiopharmaceuticals for PET imaging and targeted alpha therapy (TAT) against unmet medical needs in cancer and Orano Med. The use of radiopharmaceuticals to address unmet medical needs in cancer.
Samarium Trifluoroacetylacetonate Market Segmentation:
By Type
- 95% Purity
- 98% Purity
- 99% Purity Minimum
- Other
By Application
- Pharmacy
- Catalytic Synthesis
- Other
Samarium Trifluoroacetylacetonate Market Companies:
- American Elements
- ABCR
- ALADDIN-E
- A2B Chem
- BOC Sciences
- Chemwill Asia
- NBInno
- Strem
- Santa Cruz Biotechnology
- Volatec
- Apollo Scientific
- Arctom
- AHH Chemical.
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
scandium-market.jpg)
